Impact BioMedical, Inc. Financial Flexibility Index
Impact BioMedical, Inc. financial flexibility index. Impact BioMedical, Inc. (IBO) has a Financial Flexibility Index of -0.07x as of September 2025. Free cash flow of $-1.99 Million (operating CF $-1.99 Million minus capex $0.00) represents 0% of total liabilities ($27.06 Million). See Impact BioMedical, Inc. (IBO) free cash flow to measure how efficiently the company converts operating cash flow to free cash.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Financial Flexibility Index of Impact BioMedical, Inc. (2017–2024)
Financial flexibility index of Impact BioMedical, Inc. from 2017 to 2024. Historical Financial Flexibility Index trend for Impact BioMedical, Inc. across 8 annual periods. Check IBO operating cash flow to net income to evaluate the quality of earnings relative to operating cash generation.
Impact BioMedical, Inc. Financial Flexibility Index by Year (2017–2024)
Impact BioMedical, Inc. financial flexibility index by year from 2017 to 2024. Year-by-year free cash flow to debt coverage for Impact BioMedical, Inc.. For the full cash flow conversion analysis, see Impact BioMedical, Inc. cash conversion from operations.
| Year | Flexibility Index | Free Cash Flow (USD) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2024 | -0.43x | $-5.64 Million | $-5.64 Million | $13.05 Million | ▼ -149.5% |
| 2023 | -0.17x | $-2.83 Million | $-2.85 Million | $16.37 Million | ▲ +43.5% |
| 2022 | -0.31x | $-4.24 Million | $-4.33 Million | $13.83 Million | ▲ +89.2% |
| 2021 | -2.84x | $-2.97 Million | $-3.25 Million | $1.05 Million | ▼ -19272.8% |
| 2020 | -0.01x | $-1.14K | $-1.14K | $78.03K | ▲ +99.7% |
| 2019 | -5.54x | $-120.46K | $-121.98K | $21.72K | ▼ -54.7% |
| 2018 | -3.58x | $-71.99K | $-71.99K | $20.09K | ▲ +71.5% |
| 2017 | -12.59x | $-320.34K | $-320.34K | $25.44K | — |